(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:732370 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARRB1 mRNA CTD PMID:22079256 (S)-nicotine multiple interactions ISO RGD:732370 6480464 ARRB1 protein affects the reaction [Nicotine promotes the reaction [RB1 protein binds to RAF1 protein]], ARRB1 protein affects the reaction [Nicotine results in increased phosphorylation of and results in increased activity of SRC protein] CTD PMID:16862215 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of ARRB1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of ARRB1 mRNA] CTD PMID:22206623 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of ARRB1 mRNA CTD PMID:17555576 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:732370 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ARRB1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2156 6480464 Tetrachlorodibenzodioxin results in decreased expression of ARRB1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732370 6480464 Tetrachlorodibenzodioxin results in decreased expression of ARRB1 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:2156 6480464 2 more ... CTD PMID:32109520 2,4,6-tribromophenol increases expression ISO RGD:732370 6480464 2 more ... CTD PMID:31675489 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:2156 6480464 Trinitrobenzenesulfonic Acid results in increased expression of ARRB1 mRNA, Trinitrobenzenesulfonic Acid results in increased expression of ARRB1 protein CTD PMID:24637189 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:2156 6480464 Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ARRB1 mRNA] more ... CTD PMID:24637189 2-arachidonoylglycerol multiple interactions ISO RGD:732370 6480464 glyceryl 2-arachidonate affects the reaction [CNR1 protein affects the localization of ARRB1 protein] more ... CTD PMID:31024316 2-butoxyethanol increases expression EXP 6480464 n-butoxyethanol results in increased expression of ARRB1 mRNA CTD PMID:19812364 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of ARRB1 mRNA CTD PMID:29554273 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of ARRB1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:732370 6480464 Decitabine affects the expression of ARRB1 mRNA CTD PMID:23300844 acetamide increases expression ISO RGD:2156 6480464 acetamide results in increased expression of ARRB1 mRNA CTD PMID:31881176 aflatoxin B1 increases methylation ISO RGD:732370 6480464 Aflatoxin B1 results in increased methylation of ARRB1 intron CTD PMID:30157460 Aflatoxin B2 alpha decreases methylation ISO RGD:732370 6480464 aflatoxin B2 results in decreased methylation of ARRB1 intron CTD PMID:30157460 AH23848 multiple interactions ISO RGD:732370 6480464 [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] inhibits the reaction [[ARRB1 protein modified form binds to SRC protein] which binds to IL1R1 protein] more ... CTD PMID:19407222 alprenolol multiple interactions ISO RGD:732370 6480464 [Alprenolol co-treated with ARRB1 protein] results in increased expression of MIR125A mRNA more ... CTD PMID:18787115 , PMID:24334028 ammonium chloride affects expression ISO RGD:2156 6480464 Ammonium Chloride affects the expression of ARRB1 mRNA CTD PMID:16483693 amphetamine decreases expression ISO RGD:2156 6480464 Amphetamine results in decreased expression of ARRB1 mRNA CTD PMID:30779732 aristolochic acid A increases expression ISO RGD:732370 6480464 aristolochic acid I results in increased expression of ARRB1 mRNA CTD PMID:33212167 belinostat increases expression ISO RGD:732370 6480464 belinostat results in increased expression of ARRB1 mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:732370 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARRB1 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO RGD:732370 6480464 Benzo(a)pyrene results in decreased expression of ARRB1 mRNA CTD PMID:20064835 benzo[a]pyrene increases expression ISO RGD:732370 6480464 Benzo(a)pyrene results in increased expression of ARRB1 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:732370 6480464 Benzo(a)pyrene affects the methylation of ARRB1 intron CTD PMID:30157460 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of ARRB1 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ARRB1 mRNA CTD PMID:19770486 benzo[e]pyrene increases methylation ISO RGD:732370 6480464 benzo(e)pyrene results in increased methylation of ARRB1 intron CTD PMID:30157460 Benzo[k]fluoranthene increases expression EXP 6480464 benzo(k)fluoranthene results in increased expression of ARRB1 mRNA CTD PMID:26377693 bisphenol A decreases expression ISO RGD:2156 6480464 bisphenol A results in decreased expression of ARRB1 mRNA CTD PMID:24066056 more ... bisphenol A decreases methylation ISO RGD:732370 6480464 bisphenol A results in decreased methylation of ARRB1 gene CTD PMID:31601247 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of ARRB1 promoter CTD PMID:27334623 bisphenol A increases expression ISO RGD:732370 6480464 bisphenol A results in increased expression of ARRB1 mRNA, bisphenol A results in increased expression of ARRB1 protein CTD PMID:27685785 , PMID:34186270 Bisphenol B increases expression ISO RGD:732370 6480464 bisphenol B results in increased expression of ARRB1 protein CTD PMID:34186270 bisphenol F decreases expression ISO RGD:2156 6480464 4, 4'-bisphenol F results in decreased expression of ARRB1 mRNA CTD PMID:26186136 bisphenol F increases expression ISO RGD:732370 6480464 bisphenol F results in increased expression of ARRB1 protein CTD PMID:34186270 bortezomib decreases expression ISO RGD:732370 6480464 Bortezomib results in decreased expression of ARRB1 mRNA CTD PMID:20977926 butanal decreases expression ISO RGD:732370 6480464 butyraldehyde results in decreased expression of ARRB1 mRNA CTD PMID:26079696 caffeine decreases phosphorylation ISO RGD:732370 6480464 Caffeine results in decreased phosphorylation of ARRB1 protein CTD PMID:35688186 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:732370 6480464 Nanotubes, Carbon results in increased expression of ARRB1 mRNA CTD PMID:23634900 carvedilol multiple interactions EXP 6480464 ARRB1 gene mutant form inhibits the reaction [carvedilol results in increased expression of MIR125A mRNA] more ... CTD PMID:24334028 carvedilol multiple interactions ISO RGD:732370 6480464 [carvedilol co-treated with ARRB1 protein] results in increased expression of MIR125A mRNA more ... CTD PMID:18787115 , PMID:24334028 chlorpyrifos decreases expression ISO RGD:2156 6480464 Chlorpyrifos results in decreased expression of ARRB1 mRNA CTD PMID:17452286 cisplatin affects expression ISO RGD:732370 6480464 Cisplatin affects the expression of ARRB1 mRNA CTD PMID:23300844 cisplatin increases expression ISO RGD:732370 6480464 Cisplatin results in increased expression of ARRB1 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:732370 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of ARRB1 mRNA CTD PMID:27392435 colforsin daropate hydrochloride multiple interactions ISO RGD:732370 6480464 Colforsin inhibits the reaction [[carvedilol co-treated with ARRB1 protein] results in increased expression of MIR190A mRNA] CTD PMID:24334028 copper atom multiple interactions ISO RGD:732370 6480464 [Chelating Agents binds to Copper] which results in decreased expression of ARRB1 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of ARRB1 mRNA CTD PMID:20971185 , PMID:30911355 copper(0) multiple interactions ISO RGD:732370 6480464 [Chelating Agents binds to Copper] which results in decreased expression of ARRB1 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of ARRB1 mRNA CTD PMID:20971185 , PMID:30911355 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of ARRB1 mRNA CTD PMID:19477151 corticosterone multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [Corticosterone results in decreased expression of ARRB1 mRNA] CTD PMID:19477151 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of ARRB1 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:732370 6480464 Cyclosporine results in decreased expression of ARRB1 mRNA CTD PMID:25562108 decabromodiphenyl ether decreases expression ISO RGD:732370 6480464 decabromobiphenyl ether results in decreased expression of ARRB1 protein CTD PMID:31675489 diazinon decreases expression ISO RGD:2156 6480464 Diazinon results in decreased expression of ARRB1 mRNA CTD PMID:17452286 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARRB1 mRNA CTD PMID:30529165 dioxygen multiple interactions ISO RGD:2156 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ARRB1 mRNA CTD PMID:33729688 dobutamine multiple interactions ISO RGD:732370 6480464 ARRB1 protein promotes the reaction [Dobutamine promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK1 protein]], ARRB1 protein promotes the reaction [Dobutamine promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]] CTD PMID:18787115 dopamine multiple interactions ISO RGD:732370 6480464 Dopamine promotes the reaction [DRD2 protein affects the localization of ARRB1 protein], GRK2 protein promotes the reaction [Dopamine promotes the reaction [DRD2 protein affects the localization of ARRB1 protein]] CTD PMID:31024316 dorsomorphin multiple interactions ISO RGD:732370 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:732370 6480464 Doxorubicin results in decreased expression of ARRB1 mRNA CTD PMID:29803840 entinostat multiple interactions ISO RGD:732370 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARRB1 mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:732370 6480464 entinostat results in increased expression of ARRB1 mRNA CTD PMID:26272509 ethanol decreases expression ISO RGD:2156 6480464 Ethanol results in decreased expression of ARRB1 mRNA CTD PMID:20655511 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of ARRB1 mRNA CTD PMID:30319688 ethanol increases expression EXP 6480464 Ethanol results in increased expression of ARRB1 mRNA CTD PMID:30319688 fluoxetine multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [Corticosterone results in decreased expression of ARRB1 mRNA] CTD PMID:19477151 folic acid multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of ARRB1 mRNA] CTD PMID:22206623 genistein decreases expression ISO RGD:2156 6480464 Genistein results in decreased expression of ARRB1 mRNA CTD PMID:21782745 genistein multiple interactions ISO RGD:2156 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of ARRB1 mRNA CTD PMID:21782745 gentamycin decreases expression ISO RGD:2156 6480464 Gentamicins results in decreased expression of ARRB1 mRNA CTD PMID:33387578 glyphosate decreases expression ISO RGD:732370 6480464 glyphosate results in decreased expression of ARRB1 mRNA CTD PMID:31295307 isoprenaline multiple interactions ISO RGD:732370 6480464 Isoproterenol promotes the reaction [ADRB1 protein binds to ARRB1 protein] CTD PMID:18787115 leukotriene D4 multiple interactions ISO RGD:732370 6480464 Leukotriene D4 promotes the reaction [CYSLTR2 protein binds to ARRB1 protein] CTD PMID:33288675 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of ARRB1 mRNA CTD PMID:27339419 mercury dibromide increases expression ISO RGD:732370 6480464 mercuric bromide results in increased expression of ARRB1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:732370 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARRB1 mRNA CTD PMID:27188386 mesalamine multiple interactions ISO RGD:2156 6480464 Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ARRB1 mRNA], Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ARRB1 protein] CTD PMID:24637189 methapyrilene increases methylation ISO RGD:732370 6480464 Methapyrilene results in increased methylation of ARRB1 intron CTD PMID:30157460 methotrexate decreases expression ISO RGD:732370 6480464 Methotrexate results in decreased expression of ARRB1 mRNA CTD PMID:24449571 methoxychlor multiple interactions ISO RGD:2156 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of ARRB1 mRNA CTD PMID:21782745 methoxychlor decreases expression ISO RGD:2156 6480464 Methoxychlor results in decreased expression of ARRB1 mRNA CTD PMID:21782745 methyl methanesulfonate decreases expression ISO RGD:732370 6480464 Methyl Methanesulfonate results in decreased expression of ARRB1 mRNA CTD PMID:23649840 metoprolol multiple interactions ISO RGD:732370 6480464 Metoprolol inhibits the reaction [[carvedilol co-treated with ARRB1 protein] results in increased expression of MIR190A mRNA] CTD PMID:24334028 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of ARRB1 mRNA CTD PMID:17942915 N-nitrosodiethylamine multiple interactions ISO RGD:2156 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ARRB1 mRNA CTD PMID:20360939 N-nitrosodiethylamine multiple interactions EXP 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARRB1 mRNA] CTD PMID:17942915 nickel sulfate increases expression ISO RGD:732370 6480464 nickel sulfate results in increased expression of ARRB1 mRNA CTD PMID:22714537 nicotine multiple interactions ISO RGD:732370 6480464 ARRB1 protein affects the reaction [Nicotine promotes the reaction [RB1 protein binds to RAF1 protein]], ARRB1 protein affects the reaction [Nicotine results in increased phosphorylation of and results in increased activity of SRC protein] CTD PMID:16862215 O-methyleugenol increases expression ISO RGD:732370 6480464 methyleugenol results in increased expression of ARRB1 mRNA CTD PMID:32234424 ouabain increases expression ISO RGD:732370 6480464 Ouabain results in increased expression of ARRB1 mRNA CTD PMID:16412265 ozone increases expression ISO RGD:2156 6480464 Ozone results in increased expression of ARRB1 mRNA CTD PMID:16330353 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARRB1 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO RGD:732370 6480464 p-Chloromercuribenzoic Acid results in increased expression of ARRB1 mRNA CTD PMID:26272509 panobinostat increases expression ISO RGD:732370 6480464 panobinostat results in increased expression of ARRB1 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:732370 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARRB1 mRNA CTD PMID:27188386 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of ARRB1 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:2156 6480464 Acetaminophen results in decreased expression of ARRB1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:732370 6480464 Acetaminophen results in increased expression of ARRB1 mRNA CTD PMID:22230336 pentanal decreases expression ISO RGD:732370 6480464 pentanal results in decreased expression of ARRB1 mRNA CTD PMID:26079696 phenethyl caffeate multiple interactions ISO RGD:2156 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ARRB1 mRNA CTD PMID:20360939 phenobarbital multiple interactions EXP 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ARRB1 mRNA] CTD PMID:19482888 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of ARRB1 mRNA CTD PMID:19482888 phenylmercury acetate increases expression ISO RGD:732370 6480464 Phenylmercuric Acetate results in increased expression of ARRB1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:732370 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARRB1 mRNA CTD PMID:27188386 phosgene affects expression EXP 6480464 Phosgene affects the expression of ARRB1 mRNA CTD PMID:16300373 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of ARRB1 mRNA CTD PMID:17426115 potassium chromate multiple interactions ISO RGD:732370 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARRB1 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:732370 6480464 potassium chromate(VI) results in decreased expression of ARRB1 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of ARRB1 mRNA CTD PMID:28903501 propanal decreases expression ISO RGD:732370 6480464 propionaldehyde results in decreased expression of ARRB1 mRNA CTD PMID:26079696 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of ARRB1 mRNA CTD PMID:21278054 protein kinase inhibitor multiple interactions ISO RGD:732370 6480464 Protein Kinase Inhibitors inhibits the reaction [FASN protein affects the localization of ARRB1 protein] CTD PMID:26670611 quercetin decreases expression ISO RGD:732370 6480464 Quercetin results in decreased expression of ARRB1 mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:732370 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:732370 6480464 Silicon Dioxide analog results in decreased expression of ARRB1 mRNA CTD PMID:25895662 sodium arsenite increases expression ISO RGD:732370 6480464 sodium arsenite results in increased expression of ARRB1 mRNA CTD PMID:34032870 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of ARRB1 mRNA CTD PMID:17555576 thioacetamide increases expression ISO RGD:2156 6480464 Thioacetamide results in increased expression of ARRB1 mRNA CTD PMID:34492290 trichostatin A increases expression ISO RGD:732370 6480464 trichostatin A results in increased expression of ARRB1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:732370 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARRB1 mRNA CTD PMID:27188386 Triptolide increases expression ISO RGD:2156 6480464 triptolide results in increased expression of ARRB1 protein CTD PMID:32519852 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of ARRB1 mRNA CTD PMID:35537566 tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of ARRB1 mRNA CTD PMID:30912803 tunicamycin decreases expression EXP 6480464 Tunicamycin results in decreased expression of ARRB1 mRNA CTD PMID:17127020 valproic acid increases expression ISO RGD:732370 6480464 Valproic Acid results in increased expression of ARRB1 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:732370 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARRB1 mRNA CTD PMID:27188386 WIN 55212-2 multiple interactions ISO RGD:732370 6480464 (3R)-((2 more ... CTD PMID:31024316